Phase III double-blind study of latanoprost/timolol combination (KP2035) in patients with primary open-angle glaucoma or ocular hypertension

Japanese Journal of Clinical Ophthalmology

Volumn 63, Issue 5, 2009, Pages 807-815

  Kitazawa, Yoshiaki ^a  

^a Akasaka Kitazawa Ophthalmic Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67949085292     PISSN: 03705579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Japanese Source.
2. Japanese Source.
3. Japanese Source.
4. Miichi H, Nagataki S : Effects of pilocarpine, saĽbu-tamol, and timolol on aqueous humor formation in cynomolgus monkeys. Invest Ophthalmol Vis Sci 24 : 1269-1275,1983
5. Patel SC, Spaeth GL : Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26 : 233-236,1995
6. Robin AL, Covert D : Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 112 : 863-868, 2005
7. Japanese Source.
8. Nino J, Tahvanainen K, Uusitalo H et al: Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Clin Physiol Funct Imaging 22 : 271-278, 2002
9. Ohno Y, Iga T, Yamada Y et al : Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon® TG). Curr Eye Res 30 : 319-328, 2005
10. Higginbotham EJ, Feldman R, Stiles M et al: La-tanoprost and timolol combination therapy vs monotherapy : one-year randomized trial. Arch Ophthalmol 120 : 915-922, 2002